ADMA Biologics stock price
ADMA 바이오로직스NASDAQ:ADMA · Nasdaq · Healthcare$9.72-2.11%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →ADMA Biologics last closed at $9.72 (-2.11%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 13.3×. Its overall grade ranks 285 of 739 stocks in Healthcare.
About this company
ADMA Biologics last closed at $9.72 (-2.11%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 285/739
Valuation grade F
Related stocks
- Baxter InternationalCompetitor
면역글로불린·혈장유래 바이오의약품 시장의 주요 경쟁사
- GrifolsCompetitor
혈장유래 치료제와 면역글로불린 분야의 글로벌 경쟁사
- Takeda PharmaceuticalCompetitor
혈장유래 의약품 및 면역글로불린 사업에서 경쟁
About ADMA Biologics
- What technical signals does ADMA Biologics (ADMA) have?
- ADMA Biologics current technical signals: no active technical signal.
- Is ADMA Biologics a cup-and-handle pattern?
- No. ADMA Biologics has no valid Cup signal right now.
- What published figures are available for ADMA Biologics?
- Market cap: $2.31B. Trailing 12 months PER: 13.3×. Latest quarter PBR: 5.48×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about ADMA Biologics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy